Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06739460

Comparison of Antinociceptive Effects of Ketamine and Magnesium Used for Sedation in Hysteroscopy Cases

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
SULEYMAN SARI · Other Government
Sex
Female
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

This study aims to compare the antinociceptive effects of ketamine and magnesium used in addition to midazolam, fentanyl, propofol and remifentanil agents preferred in hysteroscopy cases. It is conducted to observe the effect of ketamine and magnesium use on total additional propofol doses and additional remifentanil doses.

Detailed description

Sedation is generally preferred in hysteroscopy cases. The most commonly used intravenous drugs are midazolam, fentanyl, propofol and remifentanil. Multimodal analgesia, which is intended to be provided in hysteroscopy cases, is a strategy that includes the use of two or more analgesic agents and techniques to provide adequate analgesia; and aims to minimize side effects such as bradycardia, hypotension, respiratory depression, pruritus, and postoperative nausea and vomiting. Multimodal analgesia improves patient and surgical comfort by applying additional drugs to existing agents, reduces postoperative complications, and thus helps to shorten hospital stays and reduce costs. Whether magnesium contributes to this multimodal analgesia will be investigated observationally, based on its antinociceptive effects.

Conditions

Timeline

Start date
2024-12-10
Primary completion
2025-01-10
Completion
2025-01-15
First posted
2024-12-18
Last updated
2024-12-18

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06739460. Inclusion in this directory is not an endorsement.

Comparison of Antinociceptive Effects of Ketamine and Magnesium Used for Sedation in Hysteroscopy Cases (NCT06739460) · Clinical Trials Directory